Work

First-line pemigatinib in a myeloid/lymphoid neoplasm with FGFR1 rearrangement: shifting the current treatment paradigm

Year: 2026

Type: article

Study design: Case Report

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2026.2757354

Authors: Christos Stafylidis, Eleni Variami, Eleftheria Lakiotaki, Iraklis Patsialos, Stavroula Syriopoulou, Konstantinos Sideris, Christina-Nefeli Kontandreopoulou, Dimitra Vlachopoulou, Sofia Stouggioti, Elena Solomou, Michaela Plaka, Nikos Georgakopoulos, Penelope Korkolopoulou, Marina Mantzourani, Panagiotis Diamantopoulos

Institutions: National and Kapodistrian University of Athens, Laiko General Hospital of Athens, University General Hospital Attikon, University of Patras, Andreas Sygros Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7225182805

FWCI:

Cites: 11

Cited by:

Related to: 10